Syndexa Obtains $15,000,000 Series B Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a6e26d76-efdb-4cfa-93c1-2d7ca419adfd&Preview=1 -
Date
5/30/2008 -
Company Name
Syndexa -
Mailing Address
767C Concord Avenue Cambridge, MA 02138 -
Company Description
The company develops drugs targeting novel biological mechanisms for the treatment and prevention of metabolic diseases including obesity, type 2 diabetes and cardiovascular disease. -
Website
http://www.syndexa.com -
Transaction Type
Venture Equity -
Transaction Amount
$15,000,000 -
Transaction Round
Series B -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Undisclosed
